Global Health and Development Forum

Theme 1: Science empowers life and health

Report 1

Title: Innovation and Curiosity Driven Research

Barry J. Marshall (Australia), Winner of 2005 Nobel Prize in

Physiology or Medicine

Report 2

Title: The development and initial validation of AI-aided thoracic surgery system

WANG Jun, Academician of the Chinese Academy of Engineering, Dean of Peking University People's Hospital

Report 3

Title: One innovation to stop the next pandemic: the Global Health Emergency Corps

Scott F. Dowell (The United States of America), Senior Advisor, Global Health Emergency Corps of WHO

Report 4

Title: Improving Pandemic Readiness and Resilience: A Dual Strategy to Invest in Health Systems

Robert Hecht (The United States of America), Professor of Yale School of Public Health

Report 5

Title: The multidisciplinary cross connection for Health Challenges

Liang Wannian (China), Executive Vice-Dean of Vanke School of Public

Health, and the Dean of Institute for Healthy China at Tsinghua University

Report 6

Title: The Evolving Landscape of Global Infectious Disease Control

Melanie Saville (The United Kingdom), Chief Scientist Officer of

PATH

Theme 2: Addressing health challenges by innovation

Report 7

Title: Innovation in disease surveillance – where do we go from here

David Blazes (The United States of America), Deputy Director for Vaccine Development & Surveillance of BMGF

Report 8

Title: Driven by innovation & Connecting the world

ZHANG Qiang (China), Chairman of United Imaging

Report 9

Title: Respiratory Diseases: Exploring Innovative Control Strategies from Treatment to Prevention

XIAO Hui (China), Head of Marketing, Vaccines & Immunotherapy Division, AstraZeneca

Report 10

Title: The Innovation of Biomedical Engineering for Global Health Challenges

WU Chengtie (China), Director of Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences

Report 11

Title: Pushing the boundaries of healthcare: Innovative approach to treating the untreatabl

Astrid Scherer (Germany), Vice President and Global Head of Product development and Performance Excellent, Bayer Group

Chair:

XU Fujie (US), Deputy Director, Head of Health Innovation and Partnership of the China Country Office, Bill & Melinda Gates Foundation

Guest 1: Renaud GABAY (France), Executive Vice President of RDPAC

Guest 2: Zhang Rumin (US),  Chief scientific officer of GHDDI

Guest 3: REN Minghui (China), Director of Institute for Global Health of Peking University, Former Assistant Director-General of WHO

Guest 4: Chin Yen TAY (Malaysia), Helicobacter Laboratory Manager,the Marshall Centre for Infectious Diseases Research & Training, University of Western Australia

Guest 5: WU Chengtie (China), Director of Suzhou Institute ofBiomedical Engineering and Technology, Chinese Academy of Sciences

Guest 6: Steve Hoffman (US), Renowned investor and entrepreneur in Silicon Valley, founder of Founder Space, the top startup accelerator in the US

Lang Lin，Deputy Director, Head of Health Innovation and Partnership of the China Country Office, Bill & Melinda Gates Foundation